These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 7907333

  • 1. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M, Herzig I, Reymann A, Brandt I, Schaefer B, Bunge A, Heidebrecht HJ, Seidel A.
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [Abstract] [Full Text] [Related]

  • 2. Reversal of multidrug resistance in Friend leukemia cells by dexniguldipine-HCl.
    Reymann A, Looft G, Woermann C, Dietel M, Erttmann R.
    Cancer Chemother Pharmacol; 1993; 32(1):25-30. PubMed ID: 8462120
    [Abstract] [Full Text] [Related]

  • 3. In vivo reversibility of multidrug resistance by the MDR-modulator dexniguldipine (niguldipine derivative B859-35) and by verapamil.
    Dietel M, Boss H, Reymann A, Pest S, Seidel A.
    J Exp Ther Oncol; 1996 Jan; 1(1):23-9. PubMed ID: 9414385
    [Abstract] [Full Text] [Related]

  • 4. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.
    Höllt V, Kouba M, Dietel M, Vogt G.
    Biochem Pharmacol; 1992 Jun 23; 43(12):2601-8. PubMed ID: 1352973
    [Abstract] [Full Text] [Related]

  • 5. Derivation and characterisation of a mouse tumour cell line with acquired resistance to cyclosporin A.
    Wright KA, Twentyman PR.
    Eur J Cancer; 1993 Jun 23; 29A(3):389-94. PubMed ID: 8104444
    [Abstract] [Full Text] [Related]

  • 6. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B, Nilsson K, Nygren P, Larsson R.
    Anticancer Drugs; 1992 Dec 23; 3(6):641-6. PubMed ID: 1363199
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S, Sone S, Nishioka Y, Naito M, Tsuruo T, Ogura T.
    Jpn J Cancer Res; 1994 Feb 23; 85(2):194-203. PubMed ID: 7511575
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J, Hamilton G, Thalhammer T, Riegler M, Cosentini EP, Ellinger A, Bischof G, Schweitzer M, Teleky B, Koperna T.
    Cancer Chemother Pharmacol; 1994 Feb 23; 34(2):125-32. PubMed ID: 7910786
    [Abstract] [Full Text] [Related]

  • 9. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S, Patel K, Singh H, Gollapudi S.
    Cancer Lett; 1994 Jan 30; 76(2-3):139-45. PubMed ID: 7511983
    [Abstract] [Full Text] [Related]

  • 10. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY, Sciandra J, Siemann DW.
    Biochem Pharmacol; 1989 Nov 01; 38(21):3697-705. PubMed ID: 2574574
    [Abstract] [Full Text] [Related]

  • 11. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT, de Vries EG, Timmer-Bosscha H, Meersma GJ, Mesander G, Vellenga E, Mulder NH.
    Cancer Res; 1994 Oct 15; 54(20):5368-73. PubMed ID: 7923167
    [Abstract] [Full Text] [Related]

  • 12. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.
    Chen YN, Mickley LA, Schwartz AM, Acton EM, Hwang JL, Fojo AT.
    J Biol Chem; 1990 Jun 15; 265(17):10073-80. PubMed ID: 1972154
    [Abstract] [Full Text] [Related]

  • 13. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 14. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G.
    J Urol; 1993 Nov 03; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [Abstract] [Full Text] [Related]

  • 15. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.
    Leontieva OV, Preobrazhenskaya MN, Bernacki RJ.
    Invest New Drugs; 2002 Feb 03; 20(1):35-48. PubMed ID: 12003193
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour.
    Van de Vrie W, Gheuens EE, Durante NM, De Bruijn EA, Marquet RL, Van Oosterom AT, Eggermont AM.
    J Cancer Res Clin Oncol; 1993 Feb 03; 119(10):609-14. PubMed ID: 8101524
    [Abstract] [Full Text] [Related]

  • 17. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
    Pilarski LM, Belch AR.
    Blood; 1994 Feb 01; 83(3):724-36. PubMed ID: 7507731
    [Abstract] [Full Text] [Related]

  • 18. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM, Yatscoff RW, Murphy GF, Belch AR.
    Leukemia; 1998 Apr 01; 12(4):505-9. PubMed ID: 9557608
    [Abstract] [Full Text] [Related]

  • 19. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
    Lopes EC, Scolnik M, Alvarez E, Hajos SE.
    Leuk Res; 2001 Jan 01; 25(1):85-93. PubMed ID: 11137565
    [Abstract] [Full Text] [Related]

  • 20. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.
    Tsuji A, Tamai I, Sakata A, Tenda Y, Terasaki T.
    Biochem Pharmacol; 1993 Sep 14; 46(6):1096-9. PubMed ID: 8105783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.